Evotec starts Phase 1 antibody trial
Evotec (NASDAQ:EVO) initiated a first-in-human Phase 1 trial of JST-018, an investigational monoclonal antibody cocktail targeting orthopoxviruses developed by its Just – Evotec Biologics subsidiary.
Evotec (NASDAQ:EVO) initiated a first-in-human Phase 1 trial of JST-018, an investigational monoclonal antibody cocktail targeting orthopoxviruses developed by its Just – Evotec Biologics subsidiary.
State Street Corporation (NYSE:STT) has named its Australia country head, Tim Helyar, as the new head of Asia Pacific.
Evion Group (ASX:EVG) identified a 200m by 200m target zone located 300m southwest of historic workings at its Carp Fluorspar Project.
Sembcorp has reportedly hired advisory firm Lazard to sell a partial equity stake in its proposed $1.5 billion Marri Wind Farm Project.
Bitmine Immersion Technologies has bought 28,086 Ethereum (CRYPTO:ETH), worth about $70 million at its stated reference price.
Canadian Phosphate (ASX:CP8) extended the mineralisation strike at its Wapiti Phosphate Project.
Block has applied to the Office of the Comptroller of the Currency to establish Builders Bank & Trust.
Metcash (ASX:MTS) reported an 11.7% growth in tobacco sales across its independent store network during the first 18 weeks of the financial year.
Hyperliquid has burned 15,350 HYPE (CRYPTO:HYPE) worth about $1.32 million through its automated burn system.
Austal (ASX:ASB) has received a non-binding offer valued at up to US$1.35 billion to sell its American division.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy